MX2013007699A - Solucion de eluyente. - Google Patents

Solucion de eluyente.

Info

Publication number
MX2013007699A
MX2013007699A MX2013007699A MX2013007699A MX2013007699A MX 2013007699 A MX2013007699 A MX 2013007699A MX 2013007699 A MX2013007699 A MX 2013007699A MX 2013007699 A MX2013007699 A MX 2013007699A MX 2013007699 A MX2013007699 A MX 2013007699A
Authority
MX
Mexico
Prior art keywords
radiofluorination
preparation
present
prepared
eluent solution
Prior art date
Application number
MX2013007699A
Other languages
English (en)
Other versions
MX363538B (es
Inventor
Ole Kristian Hjelstuen
Torild Wickstrom
Anders Svadberg
Dag M Evje
Liane Ochsenfeld
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of MX2013007699A publication Critical patent/MX2013007699A/es
Publication of MX363538B publication Critical patent/MX363538B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B9/00—General methods of preparing halides
    • C01B9/08—Fluorides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/363—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invención proporciona un novedoso método para la preparación de 18F-fluoruro (18F) para uso en reacciones de radiofluoración. El método de la invención encuentra uso especialmente en la preparación de trazadores de tomografía de emisión de positrones (PET) 18F-etiquetados. El método de la invención es particularmente ventajoso sonde las soluciones a granel son preparadas y almacenadas envíales prellenados en lugar de ser recién preparadas en el día de síntesis. La presente invención también proporciona una reacción de radiofluoración, la cual comprende el método de la invención, así como un casete para uso para realizar el método de la invención y/o el método de radiofluoración de la invención en un aparato de radiosintesis automatizado.
MX2013007699A 2010-12-29 2011-12-21 Solucion de eluyente. MX363538B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061427839P 2010-12-29 2010-12-29
PCT/EP2011/073670 WO2012089594A1 (en) 2010-12-29 2011-12-21 Eluent solution

Publications (2)

Publication Number Publication Date
MX2013007699A true MX2013007699A (es) 2013-08-15
MX363538B MX363538B (es) 2019-03-27

Family

ID=45495902

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007699A MX363538B (es) 2010-12-29 2011-12-21 Solucion de eluyente.

Country Status (16)

Country Link
US (3) US11504430B2 (es)
EP (2) EP2658831B1 (es)
JP (1) JP6018581B2 (es)
KR (3) KR102218263B1 (es)
CN (2) CN108218650A (es)
AU (1) AU2011351550B2 (es)
BR (2) BR112013015396B1 (es)
CA (1) CA2823063C (es)
DK (3) DK2658831T3 (es)
ES (2) ES2621950T3 (es)
MX (1) MX363538B (es)
PL (2) PL2658831T3 (es)
PT (2) PT3766522T (es)
RU (1) RU2608932C2 (es)
SG (1) SG10201805198TA (es)
WO (1) WO2012089594A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011351550B2 (en) * 2010-12-29 2017-02-02 Ge Healthcare Limited Eluent solution
IN2014MN00875A (es) * 2011-10-19 2015-04-17 Piramal Imaging Sa
IN2014DN03245A (es) * 2011-12-21 2015-07-10 Ge Healthcare Ltd
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
GB201214220D0 (en) * 2012-08-09 2012-09-19 Ge Healthcare Ltd Radiosynthesis
GB201221266D0 (en) 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201305687D0 (en) * 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process
EP3068747A1 (en) 2013-11-13 2016-09-21 GE Healthcare Limited Dual run cassette for the synthesis of 18f-labelled compounds
WO2015143019A2 (en) * 2014-03-18 2015-09-24 Mayo Foundation For Medical Education And Research Gaseous f-18 technologies
NL2014828B1 (en) 2015-05-20 2017-01-31 Out And Out Chemistry S P R L Method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, a device and cassette for performing this method.
JP6827709B2 (ja) * 2016-04-25 2021-02-10 日本メジフィジックス株式会社 ２−［１８ｆ］フルオロ−２−デオキシ−ｄ−グルコースの製造方法
US10695450B2 (en) 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
JP7148121B2 (ja) * 2018-08-31 2022-10-05 国立大学法人北海道大学 放射性核種１８ｆの精製方法
GB202005282D0 (en) * 2020-04-09 2020-05-27 Blue Earth Diagnostics Ltd Pharmaceutical Formulations
JP7127164B2 (ja) * 2021-01-19 2022-08-29 日本メジフィジックス株式会社 ２－［１８ｆ］フルオロ－２－デオキシ－ｄ－グルコースの製造方法
CN113372399A (zh) * 2021-06-04 2021-09-10 江苏华益科技有限公司 一种氟[18f]脱氧葡糖注射液的合成方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5425063A (en) * 1993-04-05 1995-06-13 Associated Universities, Inc. Method for selective recovery of PET-usable quantities of [18 F] fluoride and [13 N] nitrate/nitrite from a single irradiation of low-enriched [18 O] water
ZA978758B (en) * 1996-10-02 1999-03-30 Du Pont Merck Pharma Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents
RU2165266C1 (ru) * 2000-06-28 2001-04-20 Центральный научно-исследовательский рентгенорадиологический институт Способ получения [2-18f]-2-дезоксиглюкозы
EP1356827A1 (en) 2002-04-24 2003-10-29 Mallinckrodt Inc. Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution
ATE473019T1 (de) 2002-11-05 2010-07-15 Ion Beam Applic Sa Stabilisierung von wässerigen zusammensetzungen von 18f-markiertem 2-fluoro-2-deoxy-d-glukose mit ethanol
GB0422004D0 (en) * 2004-10-05 2004-11-03 Amersham Plc Method of deprotection
GB0425501D0 (en) * 2004-11-19 2004-12-22 Amersham Plc Fluoridation process
US7235216B2 (en) * 2005-05-01 2007-06-26 Iba Molecular North America, Inc. Apparatus and method for producing radiopharmaceuticals
GB0524851D0 (en) * 2005-12-06 2006-01-11 Ge Healthcare Ltd Radiolabelling method using polymers
JP5916039B2 (ja) 2006-06-21 2016-05-11 ジーイー・ヘルスケア・リミテッド 放射性医薬品製品
WO2008056481A1 (fr) 2006-11-09 2008-05-15 Nihon Medi-Physics Co., Ltd. Agent d'imagerie de diagnostic radioactif
RU2445120C2 (ru) 2006-12-21 2012-03-20 Нихон Меди-Физикс Ко., Лтд. Радиоактивный агент для диагностической визуализации
CA2678020C (en) 2007-02-13 2015-03-24 Nihon Medi-Physics Co., Ltd. Method for production of radiation diagnostic imaging agent
EP2017359A3 (en) * 2007-06-11 2009-08-05 Trasis S.A. Method for the elution of 18F fluoride trapped on an anion-exchange resin in a form suitable for efficient radiolabeling without any evaporation step
KR101009712B1 (ko) 2007-02-22 2011-01-19 재단법인 아산사회복지재단 양성자성 용매와 이에 녹는 염들을 이용한 음이온 교환고분자 지지체로부터의 플루오린-18 플루오라이드 용리와이를 이용한 플루오린-18의 표지방법
WO2008106442A1 (en) * 2007-02-27 2008-09-04 Ge Healthcare Limited Synthesis of [18f] fluoromethyl benzene using benzyl pentafluorobenzenesulfonate
EP1990310A1 (en) * 2007-04-23 2008-11-12 Trasis S.A. Method for the preparation of reactive 18F fluoride, and for the labeling of radiotracers, using a modified non-ionic solid support and without any evaporation step
WO2009045535A2 (en) * 2007-10-04 2009-04-09 Sloan-Kettering Institute For Cancer Research Fluorine-18 derivative of dasatinib and uses thereof
DK2230229T3 (en) * 2007-12-19 2017-01-23 Nihon Mediphysics Co Ltd Process for the preparation of radioactive-fluoro-labeled organic compound
US20090171272A1 (en) 2007-12-29 2009-07-02 Tegg Troy T Deflectable sheath and catheter assembly
RU2475448C2 (ru) 2008-01-03 2013-02-20 ДжиИ ХЕЛТКЕР ЛИМИТЕД Способ обработки фторида
EP2110367A1 (en) * 2008-04-14 2009-10-21 Bayer Schering Pharma Aktiengesellschaft Purification strategy for direct nucleophilic procedures
GB0819293D0 (en) * 2008-10-21 2008-11-26 Hammersmith Imanet Ltd Radiofluorination
EP2373597A2 (en) * 2008-12-04 2011-10-12 Bayer Pharma Aktiengesellschaft Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation
TW201033713A (en) 2009-03-03 2010-09-16 Wintek Corp Reflective color-changing liquid crystal display
BR112012030935B1 (pt) * 2010-04-06 2020-11-17 Life Molecular Imaging Sa método para a produção de ligantes de beta-amiloide marcados com f-18
AU2011351550B2 (en) * 2010-12-29 2017-02-02 Ge Healthcare Limited Eluent solution
GB201214220D0 (en) * 2012-08-09 2012-09-19 Ge Healthcare Ltd Radiosynthesis

Also Published As

Publication number Publication date
KR102218263B1 (ko) 2021-02-22
DK3766522T3 (da) 2022-06-13
WO2012089594A1 (en) 2012-07-05
EP3766522A1 (en) 2021-01-20
BR112014015042B1 (pt) 2021-10-26
EP3766522B1 (en) 2022-03-23
RU2608932C2 (ru) 2017-01-26
SG10201805198TA (en) 2018-07-30
US20190192660A1 (en) 2019-06-27
EP2658831B1 (en) 2017-02-15
BR112013015396A2 (pt) 2016-09-20
CN103270004A (zh) 2013-08-28
KR20190119673A (ko) 2019-10-22
BR112014015042A8 (pt) 2017-07-04
DK2658831T3 (en) 2017-04-24
JP2014508731A (ja) 2014-04-10
BR112013015396B1 (pt) 2021-11-03
ES2621950T3 (es) 2017-07-05
KR102137348B1 (ko) 2020-07-23
MX363538B (es) 2019-03-27
AU2011351550A1 (en) 2013-07-25
AU2011351550B2 (en) 2017-02-02
BR112014015042A2 (pt) 2017-06-13
PT3766522T (pt) 2022-06-14
CN108218650A (zh) 2018-06-29
ES2917875T3 (es) 2022-07-12
PL3766522T3 (pl) 2022-07-04
CA2823063A1 (en) 2012-07-05
CA2823063C (en) 2020-08-11
KR20190008994A (ko) 2019-01-25
US20230068052A1 (en) 2023-03-02
PT2793954T (pt) 2021-01-06
RU2013126979A (ru) 2015-03-20
US20130324715A1 (en) 2013-12-05
JP6018581B2 (ja) 2016-11-02
KR20130132892A (ko) 2013-12-05
PL2658831T3 (pl) 2017-07-31
EP2658831A1 (en) 2013-11-06
DK2793954T3 (da) 2021-01-04
US11504430B2 (en) 2022-11-22

Similar Documents

Publication Publication Date Title
MX363538B (es) Solucion de eluyente.
HK1255702A1 (zh) 用於合成顯像劑的自動反應系統，暗盒和裝置
MX2018008168A (es) Inhibidores de antigenos de membrana especificos de la prostata (psma) basados en la urea para imaginologia y terapia.
MX2022014611A (es) Compuestos para tomografia por emision de positrones.
MX353254B (es) Radioligandos marcados con fluor-18 y carbono-11 para la formacion de imagenes por tomografia de emision de positrones para proteina cinasa 2 de repeticion rica en leucina (lrrk2).
MX2011010295A (es) Reactivos de radiomarcado y metodos.
MX2013012793A (es) Aminoacidos radiomarcados para imagen de diagnostico.
NZ705827A (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
CL2011000237A1 (es) Compuestos adecuados para marcar o ya marcados con 18f , derivados d epiridina, ligando del receptor periferico de benzodiazepina para el diagnostico por imagenes mediante topografia de emisión de positrones (pet); composición farmaceutica; kit farmaceutico.
MX2012014117A (es) Metodo para la produccion de ligandos beta amiloide marcados con 18f.
UA110128C2 (uk) Індолкарбоксаміди та бензімідазолкарбоксаміди як інсектициди та акарициди
EP2463263A4 (en) ISOTOPE-MARKED 2-ARYLPROPIONIC ACID COMPOUNDS, PROCESS FOR PRODUCING THE SAME, MOLECULAR PROBE FOR POSITRON EMISSION TOMOGRAPHY (PET), AND CYCLO-OXYGENASE IMAGING METHOD AND ANALOGY THEREFOR
AU2010332841A8 (en) Prostate specific membrane antigen inhibitors
MX2013006202A (es) Metodo de radioconjugacion.
EA201401273A1 (ru) Набор и способ получения радиофармацевтического препарата
LT2625163T (lt) (3s,3s`) 4,4`-disulfandiil-bis-(3-aminobutan-1-sulfonrūgšties) gavimo būdas
WO2015143019A3 (en) Gaseous f-18 technologies
MX340487B (es) Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central.
WO2012157900A3 (ko) 18f-표지 pet 방사성의약품의 전구체 및 그 제조방법
MX2013007188A (es) Simplificacion de proceso para compuesto precursor.
WO2012033374A3 (ko) 1,2,3-트리아졸륨 염을 갖는 설포네이트 전구체, 그 제조방법 및 이를 사용하는 분자내 친핵성 플루오르화반응
NZ708849A (en) Radiopharmaceutical products for diagnosis and therapy of adrenal carcinoma
MX2011011191A (es) Nuevas moléculas precursoras para marcadores de pet marcados con f-18.
WO2009033584A3 (en) Diagnostic agents for positron emission imaging using f-18 radio-labeled amino-alcohols
MX2013007186A (es) Purificacion de compuesto precursor mediante cristalizacion.